1. Home
  2. SAMG vs OKYO Comparison

SAMG vs OKYO Comparison

Compare SAMG & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercrest Asset Management Group Inc.

SAMG

Silvercrest Asset Management Group Inc.

HOLD

Current Price

$10.71

Market Cap

79.3M

Sector

Finance

ML Signal

HOLD

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

HOLD

Current Price

$1.69

Market Cap

81.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAMG
OKYO
Founded
2002
2007
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.3M
81.3M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
SAMG
OKYO
Price
$10.71
$1.69
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.33
AVG Volume (30 Days)
69.7K
91.6K
Earning Date
05-01-2026
07-18-2025
Dividend Yield
6.36%
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$91,358,000.00
N/A
Revenue This Year
$8.99
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$354.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.01
$1.42
52 Week High
$16.97
$3.35

Technical Indicators

Market Signals
Indicator
SAMG
OKYO
Relative Strength Index (RSI) 47.66 58.01
Support Level N/A $1.47
Resistance Level $11.74 $1.72
Average True Range (ATR) 0.53 0.09
MACD 0.09 0.02
Stochastic Oscillator 35.91 56.41

Price Performance

Historical Comparison
SAMG
OKYO

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income, and cash, as well as non-traditional investment strategies including hedge funds, private equity funds, real estate, and commodities. The firm offers a full suite of complementary and customized family office services for families seeking comprehensive oversight of their financial affairs. The company derives revenues from Managed accounts, Silvercrest funds, Tax and family office services, and Fund administration. The firm generates the majority of its revenue from Managed Accounts.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: